BIOMIT Center for Molecular Immunology - CIM





The Cuban Medicines Regulatory Agency CECMED grants the Sanitary License of Pharmaceutical Operations for five years and Certificate of Good Manufacturing Practices to the Productive System of #Soberana.
The License was also granted to the production systems of Bio Cen and our Center, chained to the #Soberanas.
This license is granted by CECMED after an inspection of the production plants and a review of the documentation.


Today the CIM received the status of a ¨National Distinguished¨ Center granted by the National Secretariat of the Union of Health Workers.
At the same time they were recognized:
The union vanguards of 2020.
The new militants of the PCC.
The external institutions with an impact on the productive performance of the CIM: Empresas Aguas de la Habana and Sanitation Basic of Havana.
CIM Vaccination Center staff, for the work in health intervention with Soberana02 + SoberanaPlus (Days: 56 / Dose: 5289).


This morning we received at our Center the First Secretary of the Central Committee of the Communist Party of Cuba and President of the Republic of Cuba, Miguel Díaz Canel Bermúdez.

At first, General Director Eduardo Ojito Magaz made a presentation on the status of RBD antigen production and explained the challenges that the development of the protein in such a short time has imposed for our group.

Later they went to the interior of the facility (ANTYTER) to verify the productive and technological capacities in which the production of said protein takes place.

At the end of his tour, he exchanged with young researchers linked to the COVID19 Project, to whom he showed his admiration and gratitude for the work carried out in confronting the pandemic, and expressed:

¨Thanks to you we are more sovereign¨


This afternoon, in celebration of World Environment Day, an ecological garden was officially inaugurated at the CIM, which will serve as a complement for the preparation of food for our workers. This initiative is part of a group of actions that the Center has carried out several years ago in order to become certified as a Green Company. Among the largest projects promoted by the CIM are the installation of solar panels, the self-supply of water with the recovery of half of the water consumption from the installation of the water treatment plant and very soon the commitment to the gradual replacement of traditional cars by electric ones.


This Monday, May 17, the CIM vaccination center reopened for the 3rd dose of immunization of its workers with #SoberanaPlus. For 3 months, doctors and nurses from the Center have dedicated themselves full time to this task, which will conclude in just two weeks with the immunization of more than 1000 workers, who -at the same time- have been involved in the evaluation of samples of subjects included in the different phases of clinical trials of Cuban vaccine candidates, the same ones who have been working on the development and production of the Sovereign RBD antigen, as well as, in the manufacture of products for the treatment of COVID19 : itolizumab and erythropoietin.

For this reason, as a celebration of what it represents for the institution and its workers to perceive the result of all the effort and work carried out, an exhibition of Coronarisas vs. Cornavirus cartoons was inaugurated by the cartoonist Jorge Sánchez (JORGE). This will be exhibited for a month so that everyone has the opportunity to enjoy more than 80 works loaded with an intelligent Cuban humor, which not only summons us to laughter, but also to reflection.


This morning the Soberana_CIM vaccination center reopened to continue vaccinating workers with the second dose of Soberana 02.

By the way, the Cuban artist Víctor Mora, visited us to deliver a plastic work of his authorship that pays tribute to the work of the medical and scientific staff of the institution, who in this period of pandemic have stood out for their participation in various tasks inside and outside the Center, to which is added this controlled intervention study process in the company.

Data of the work:
Title: Stay home.
Size: 100x 70 CM
Acrylic / Canvas Technique.
Year: 2020
Artist: Víctor Francisco Hernández Mora (Víctor Mora)

It was made at the beginning of the pandemic in Cuba as a tribute to the medical and scientific community and to the authorities; in short, everyone who was on the red line. Amen to propose that people stay at home to win the battle against COVID19


The CIM is certified as one of the vaccinations that will be part of the intervention study of 150 thousand volunteers in Havana.
The medical and nursing team is made up of specialists from our institution who were trained for the task.
Today the vaccination begins with the first dose of Soberana02 to more than 100 of our workers.


Program: Biotechnology, Pharmaceutical Industry and Medical Technology

Projects: 1. Use of Itolizumab for the treatment of systemic inflammation produced in different pathological scenarios

2. Development of a nanoparticle with immunomodulatory and adjuvant effect for vaccines for the treatment of cancer patients.

3. Evaluation of the non-alpha IL2 Mutein (mIL2 noα) as a safe and effective therapeutic formulation for the treatment of cancer patients.

4. Increased use and clinical efficacy of CIMAvax-EGF

5. Development of biosimilar antibodies for the treatment of cancer.

Program: National Neuroscience and Neurotechnology Program

Projects: 1. NeuroEPO, medicine for the treatment of neurodegenerative diseases.

Program: Aging Longevity and Health.

Projects: 1. Immunosenescence, inflammation and cancer


The National Secretariat of the Federation of Cuban Women awarded the CIM the 60th Anniversary Flag of the Women's Organization, as a special recognition and token of gratitude from the Cuban women, for the faithful dedication to make available to the people the product of the scientific ingenuity and creator of our workers.


The General Director of our Center, Eduardo Ojito Magaz, explained to the press the capacities and productive potential of the CIM that have allowed the release of the 340 thousand doses of the Soberana02 vaccine candidate that will begin the phase III clinical trial in March.
Our Director of the Therapeutic Antibodies Plant Danais Alfonso also explained the complexities of the phases of the production process, specifying that the 2nd fermentation campaign of 500L of Soberana02 RBD antigen is already underway.

Mostrando 10 de 59 registros
Phone Board:
General Direction:
15 Street and 216 Street, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba
Postal Code:
11 600
Post Office Box:
16 040

Frequent Questions

How can I access the therapeutic vaccines against lung cancer?

Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.

How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.

-Cuban Medical Services. Web page:; E-mail:
Phone: (537) 209-0977 Fax: (537) 203-1590.

You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:

International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email:

International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email:

Mas preguntas frecuentes...


We ensure the quality, safety and effectiveness of our medicines.
We offer information on the use of our products to patients, families and professionals.
Your contribution is very important..
Report suspected adverse reactions here: